Company Filing History:
5 out of 870 
5 out of 5,081 
Years Active: 2015-2024
Title: Clarisse Lorin: Innovator in Vaccine Development
Introduction
Clarisse Lorin is a prominent inventor based in Paris, France. She has made significant contributions to the field of vaccine development, particularly through her innovative work with recombinant measles viruses. With a total of 5 patents, her research has the potential to impact public health positively.
Latest Patents
One of her latest patents is titled "Recombinant measles viruses expressing epitopes of antigens of RNA viruses—use for the preparation of vaccine compositions." This invention relates to a recombinant measles virus that expresses a heterologous amino acid sequence derived from an antigen of a specific RNA virus. The recombinant measles virus is capable of eliciting a humoral and/or cellular immune response against both the measles virus and the RNA virus. Additionally, it pertains to the use of this recombinant measles virus for the preparation of immunogenic compositions.
Career Highlights
Clarisse has worked with esteemed organizations such as the Centre National de la Recherche Scientifique and Institut Pasteur. Her work in these institutions has allowed her to advance her research and contribute to the scientific community significantly.
Collaborations
Throughout her career, Clarisse has collaborated with notable colleagues, including Lucile Mollet and Frederic Tangy. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Clarisse Lorin's contributions to vaccine development through her innovative patents and collaborations highlight her role as a leading inventor in the field. Her work continues to pave the way for advancements in immunology and public health.